Cargando…
PPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes
Chemically synthesized ligands for nuclear receptors of the PPAR family modulate a number of physiological functions, particularly insulin resistance in the context of energy homeostasis and the metabolic syndrome. Additionally, these compounds may treat or prevent the development of many secondary...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2467456/ https://www.ncbi.nlm.nih.gov/pubmed/18645617 http://dx.doi.org/10.1155/2008/230893 |